Mindpeak Breast Suite

The Mindpeak Breast Suite
provides a comprehensive suite
of proven AI algorithms,
designed to co-pilot and
empower you in breast cancer
assessments.
*Only certain Mindpeak AI models are CE-IVD marked for diagnostic use in EU. In all other countries, the use is limited to Research Use Only, not for use in diagnostic procedures.
Automated Whole Slide Analysis:
Ensuring Comprehensive Coverage
Our AI products offers fully automated whole slide analysis, ensuring that no crucial detail is overlooked. By meticulously scanning the entire slide, it enables pathologists to focus on high-priority areas, improving diagnostic accuracy and reducing the chances of missing vital information.


Precise Tissue Segmentation:
Accurately Identifying Key Areas
With advanced tissue segmentation, our AI precisely identifies and isolates the relevant regions within each whole slide image (WSI). This allows pathologists to focus on the most important tissue areas, streamlining their workflow while ensuring that critical data is highlighted and easily accessible.
Subcellular Classification:
Unlocking Deeper Diagnostic Insights
Our platform leverages AI to provide accurate subcellular classification, delivering insights at both the cellular and subcellular levels. This enhanced precision helps pathologists better understand tissue characteristics, leading to more informed and confident diagnostic decisions.


Intuitive User Interface:
Streamlining Workflow Efficiency
Designed for ease of use, our platform’s intuitive interface makes navigating complex datasets simple. Pathologists can seamlessly access AI-powered insights and visualizations, improving workflow efficiency and enabling quicker, more reliable decision-making.
Mindpeak Breast AI Algorithms
Mindpeak Breast Metastasis Detector
Efficient and fast detection of lymph node metastasis
Finding metastases in H&E stained breast lymph node tissue can require significant time and efforts. Our Metastasis Detection supports cancer experts by detecting and visualizing metastases associated with breast adenocarcinoma.

Mindpeak Breast HER2
0-Click AI solution to detect and quantify HER2 in breast cancer tissue
Mindpeak Breast HER2 is a software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples. It is a stand-alone software module which supports the analysis of digital images acquired by scanning the fixed and HER2 stained samples of invasive ductal and lobular carcinoma.

Mindpeak Breast H&E
0-click solution for the detection of invasive breast cancer
Mindpeak Breast H&E is an advanced AI solution designed for the primary analysis of breast cancer. It precisely detects invasive carcinoma and ductal carcinoma in situ (DCIS), directing attention to clinically relevant areas to assist in accurate and informed analytic decision-making.

Mindpeak Breast ER / PR
0-click AI solution to detect and quantify ER/PR in breast cancer cells
Mindpeak Breast ER/PR is a software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples. It is a stand-alone software module that supports the analysis of digital images acquired by scanning the fixed and ER/PR stained samples of invasive ductal and lobular carcinoma without the need for manual fine-tuning to your lab.

Mindpeak Breast Ki-67 HS
The very first 0-click AI solution to detect and quantify Ki-67 in tumor regions of interest according to the hotspot method
Mindpeak Breast Ki-67 HS is a software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples. It is a stand-alone software module that supports the analysis of digital images acquired by scanning the fixed and Ki-67 stained samples of invasive ductal and lobular carcinoma without the need for manual fine-tuning it to your lab.

More Solutions from Mindpeak
Compare Solutions
Get Pathology News Delivered to Your Inbox
Learn More
Mindpeak News
Revolune and MindPeak to Showcase Integrated Multiplex Immunofluorescence Workflow at AACR 2026
Editor2026-04-24T14:52:19+00:00April 17, 2026|
From Research to Routine: High-Throughput Spatial Biology with ZEISS and Mindpeak
Editor2026-05-22T14:18:19+00:00April 9, 2026|
Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials
Editor2026-04-02T10:53:35+00:00March 25, 2026|
The Push for Biomarker Testing Equity
Editor2026-03-25T10:52:59+00:00March 23, 2026|
Mindpeak and IQVIA Laboratories Are Working Together to Advance Biomarker-driven Clinical Trials
Editor2026-03-04T09:20:32+00:00February 27, 2026|
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
Editor2026-03-02T14:44:14+00:00February 25, 2026|
Tubulis and Mindpeak Announce Strategic Collaboration to Advance Cancer Innovation
Editor2025-12-18T13:34:10+00:00December 17, 2025|









Reviews
There are no reviews yet.